Leo Thomas
Impact in
-
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
- Biochemistry top 5%
Papers in
-
- Diabetes Treatment and Management 8
- Co-authors
- Frank Himmelsbach (5 shared papers)Matthias Eckhardt (5 shared papers)Michael Mark (5 shared papers)Moh Tadayyon (4 shared papers)Thomas Klein (3 shared papers)Elke Langkopf (3 shared papers)Rolf Grempler (2 shared papers)Achim Sauer (2 shared papers)
- Journals
- Journal of Epidemiology & Community Health (6 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Diabetes Obesity and Metabolism (3 papers)Blood (2 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Leo Thomas
45 papers receiving 2.0k citations
Leo Thomas's Hit Papers
Peers
Comparison fields: 5 of 126
- Endocrinology, Diabetes and Metabolism 1.0k
- Biochemistry 103
- Nutrition and Dietetics 190
- Oncology 311
- Cellular and Molecular Neuroscience 202
Countries citing papers authored by Leo Thomas
This map shows the geographic impact of Leo Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Thomas more than expected).
Fields of papers citing papers by Leo Thomas
This network shows the impact of papers produced by Leo Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Thomas. The network helps show where Leo Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Leo Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors Hit paper breakdown → | 2011 | 510 |
| 2 | 2008 | 249 | |
| 3 | 2007 | 241 | |
| 4 | 1984 | 137 | |
| 5 | 1998 | 110 | |
| 6 | 2012 | 94 | |
| 7 | 2017 | 93 | |
| 8 | 2022 | 86 | |
| 9 | 1981 | 49 | |
| 10 | 2011 | 43 | |
| 11 | 1983 | 39 | |
| 12 | 1963 | 35 | |
| 13 | 2008 | 32 | |
| 14 | 2009 | 32 | |
| 15 | 2009 | 29 | |
| 16 | 2012 | 29 | |
| 17 | 2008 | 27 | |
| 18 | 1966 | 24 | |
| 19 | 1983 | 22 | |
| 20 | 1987 | 20 |
About Leo Thomas
Leo Thomas is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Organic Chemistry, Cellular and Molecular Neuroscience and Nutrition and Dietetics, having authored 49 papers that have together received 2.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Chemical Thermodynamics and Molecular Structure (6 papers), Fatty Acid Research and Health (5 papers), Phase Equilibria and Thermodynamics (5 papers), Thermodynamic properties of mixtures (4 papers), Pancreatic function and diabetes (4 papers), Radiation Therapy and Dosimetry (3 papers) and Advanced Thermodynamics and Statistical Mechanics (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.0k citations), Biochemistry (103 citations), Nutrition and Dietetics (190 citations), Oncology (311 citations) and Cellular and Molecular Neuroscience (202 citations). Leo Thomas has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Frank Himmelsbach, Matthias Eckhardt, Michael Mark, Moh Tadayyon, Thomas Klein, Elke Langkopf, Rolf Grempler, Achim Sauer, Peter Eickelmann and Remko A. Bakker. Their work appears in journals such as Journal of Epidemiology & Community Health, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Diabetes Obesity and Metabolism and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.